Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Lung cancer

Giuseppe Giaccone¹, Egbert Smit

¹Division of Medical Oncology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands. G.Giaccone@vumc.nl

Cancer Chemotherapy and Biological Response Modifiers

|September 2, 2004

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Corrigendum to 'Final Analysis Results and Patient-Reported Outcomes From DESTINY-Lung02-A Dose-Blinded, Randomized, Phase 2 Study of Trastuzumab Deruxtecan in Patients With HER2-Mutant Metastatic NSCLC' [Journal of Thoracic Oncology Volume 20 Issue 12 (2025) 1814-1828].

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

Same author

Developments of MEK inhibitors as future cancer therapies: what have we learned from preclinical and clinical studies?

Expert opinion on investigational drugs·2025

Same author

Longitudinal Genomic Analysis of Five Cases of Recurrent Thymomas.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2025

Same author

Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group.

Lung cancer (Amsterdam, Netherlands)·2025

Same author

Avelumab combined with axitinib for patients with advanced thymoma B3 and thymic carcinoma.

Cancer·2025

Same author

Heterogeneity of progression-free survival surrogacy by sex in randomized trials testing immunotherapy in non-small cell lung cancer.

JNCI cancer spectrum·2025